The role of 5-HTT LPR and GNβ3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS)

Digestive Diseases and Sciences

Volumn 57, Issue 10, 2012, Pages 2650-2657

  Saito, Yuri A ^a   Larson, Joseph J ^a   Atkinson, Elizabeth J ^a   Ryu, Euijung ^a   Almazar, Ann E ^a   Petersen, Gloria M ^a   Talley, Nicholas J ^a,b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Genes; Genetics; Infection; Irritable bowel syndrome

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; CASE-CONTROL STUDIES; EPIGENESIS, GENETIC; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84867864859     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2319-9     Document Type: Article

References (40)

1. Saito YA, Zimmerman JM, Harmsen WS, et al. Irritable bowel syndrome aggregates strongly in families: a family-based casecontrol study. Neurogastroenterol Motil. 2008;20:790-797.
2. Locke GR III, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ III. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc. 2000;75:907-912.
3. Whorwell PJ, McCallum M, Creed FH, Roberts CT. Non-colonic features of irritable bowel syndrome. Gut. 1986;27:37-40.
4. Mohammed I, Cherkas LF, Riley SA, Spector TD, Trudgill NJ. Genetic influences in irritable bowel syndrome: a twin study. Am J Gastroenterol. 2005;100:1340-1344.
5. Morris-Yates A, Talley NJ, Boyce PM, Nandurkar S, Andrews G. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol. 1998;93:1311-1317.
6. Bengtson MB, Ronning T, Vatn MH, Harris Jr. Irritable bowel syndrome in twins: genes and environment. Gut. 2006;55:1754- 1759.
7. Levy RL, Jones KR, Whitehead WE, Feld SI, Talley NJ, Corey LA. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology. 2001; 121:799-804.
8. Saito YA, Petersen GM, Locke GR 3rd, Talley NJ. The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005;3:1057-1065.
9. Camilleri CE, Carlson PJ, Camilleri M, et al. A study of candidate genotypes associated with dyspepsia in a U.S. Community. Am J Gastroenterol. 2006;101:593-595.
10. Holtmann G, Siffert W, Haag S, et al. G-protein beta 3 subunit 825 cc genotype is associated with unexplained (functional) dyspepsia. Gastroenterology. 2004;126:971-979.
11. Vergne DE, Nemeroff CB. The interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for major depression. Curr Psychiatry Rep. 2006;8:452-457.
12. Serretti A, Chiesa A, Calati R, Perna G, Bellodi L, De Ronchi D. Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. Int Clin Psychopharmacol. 2009;24:1-18.
13. Fukudo S, Kanazawa M, Mizuno T, et al. Impact of serotonin transporter gene polymorphism on brain activation by colorectal distention. NeuroImage. 2009;47:946-951.
14. Camilleri M, Atanasova E, Carlson PJ, et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology. 2002;123:425-432.
15. Van Kerkhoven LA, Laheij RJ, Jansen JB. Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26:979- 986.
16. Brown GW, Harris TO. Depression and the serotonin transporter 5-httlpr polymorphism: a review and a hypothesis concerning gene-environment interaction. J Affect Disord. 2008;111:1-12.
17. Rosskopf D, Busch S, Manthey I, Siffert W. G protein beta 3 gene: structure, promoter, and additional polymorphisms. Hypertension. 2000;36:33-41.
18. Lee HJ, Cha JH, Ham BJ, et al. Association between a g-protein beta3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenom J. 2004;4:29-33.
19. Lindemann M, Virchow S, Ramann F, et al. The G protein beta3 subunit 825T allele is a genetic marker for enhanced T cell response. FEBS Lett. 2001;495:82-86.
20. Camilleri M, Busciglio I, Carlson P, et al. Candidate adrenergic, GMb3, and serotonergic polymorphisms, endophenotype, pharmacogenetics of clonidine in irritable bowel syndrome and health. Gastroenterology 2008;134:A-682.
21. Andresen V, Camilleri M, Kim HJ, et al. Is there an association between GMb3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology. 2006;130:1985-1994.
22. Thabane M, Kottachchi D, Marshall J. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26: 535-544.
23. Thompson WG, Creed FH, Drossman DA, Heaton KW, Mazzacca G. Functional bowel disease and functional abdominal pain. Gastrenterol Int. 1992;5:75-91.
24. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45:II43-II47.
25. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480-1491.
26. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ III. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc. 1990;65:1456-1479.
27. Attanasio V, Andrasik F, Blanchard EB, Arena JG. Psychometric properties of the SUNYA revision of the psychosomatic symptom checklist. J Behav Med. 1984;7:247-257.
28. Beck AT, Steer RA. Manual for the Beck Anxiety Inventory. San Antonio: Psychological Corporation; 1990.
29. Haringsma R, Engels GI, Beekman AT, Spinhoven P. The criterion validity of the center for epidemiological studies depression scale (CES-D) in a sample of self-referred elders with depressive symptomatology. Int J Geriatr Psychiatry. 2004;19: 558-563.
30. Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci. 1998; 43:400-411.
31. Drossman DA, Patrick DL, Whitehead WE, et al. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol. 2000;95:999-1007.
32. Lesch KP, Bengel D, Heils A, et al. Association of anxietyrelated traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527-1531.
33. Siffert W, Forster P, Jockel KH, et al. Worldwide ethnic distribution of the g protein beta3 subunit 825t allele and its association with obesity in Caucasian, Chinese, and black African individuals. J Am Soc Nephrol. 1999;10:1921-1930.
34. Locke GR, 3rd, Zinsmeister AR, Fett SL, Melton LJ, 3rd, Talley NJ. Overlap of gastrointestinal symptom complexes in a U.S. community. Neurogastroenterol Motil. 2005;17:29-34.
35. Virchow S, Ansorge N, Rubben H, Siffert G, Siffert W. Enhanced fMLP-stimulated chemotaxis in human neutrophils from individuals carrying the G protein beta3 subunit 825 T-allele. FEBS Lett. 1998;436:155-158.
36. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122:1140-1156.
37. Talley NJ, Howell S, Poulton R. The irritable bowel syndrome and psychiatric disorders in the community: is there a link? Am J Gastroenterol. 2001;96:1072-1079.
38. Drossman DA. Irritable bowel syndrome and sexual/physical abuse history. Eur J Gastroenterol Hepatol. 1997;9:327-330.
39. Gray GC, Reed RJ, Kaiser KS, Smith TC, Gastanaga VM. Selfreported symptoms and medical conditions among 11,868 Gulf War-era veterans: the Seabee Health Study. Am J Epidemiol. 2002;155:1033-1044.
40. Hudson JI, Mangweth B, Pope HG Jr, et al. Family study of affective spectrum disorder. Arch Gen Psychiatry. 2003;60:170- 177.